Global Iron Deficiency Anemia Therapy Market Size To Exceed USD 10.26 Billion By 2035 | CAGR Of 6.6%

Global Iron Deficiency Anemia Therapy Market Size To Exceed USD 10.26 Billion By 2035

According to a research report published by Spherical Insights & Consulting, The Global Iron Deficiency Anemia Therapy Market Size is Expected To Grow from USD 5.08 Billion in 2024 to USD 10.26 Billion by 2035, at a CAGR of 6.6% during the forecast period 2025-2035.

Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the " Global Iron Deficiency Anemia Therapy Market Size, Share, and COVID-19 Impact Analysis, By Type (Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusions, and Others), By Age Group (Adults, Pediatric, and Geriatric), By End-user (Clinics, Hospitals, and Home Healthcare), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035. "Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/iron-deficiency-anemia-therapy-market   

The Iron Deficiency Anemia (IDA) Therapy Market Size involves treatments aimed at restoring healthy iron levels and supporting red blood cell production in patients with anemia caused by inadequate intake or poor absorption of iron. IDA remains one of the most widespread nutritional disorders worldwide, affecting women of reproductive age, children, and individuals with chronic illnesses. Therapeutic options include oral iron supplements, intravenous iron formulations, and innovative fixed-dose combinations designed to improve absorption and reduce side effects. Rising anemia prevalence, greater awareness of nutritional deficiencies, and expanding healthcare infrastructure in emerging regions are key growth drivers. Rapid adoption of advanced IV iron therapies is fueled by their efficacy and faster response in severe cases. Nanoparticle-based and controlled-release iron therapies are broadening the treatment landscape, offering improved safety and adherence. Untapped markets in the Asia Pacific, Latin America, and Africa present significant opportunities, supported by government initiatives combating malnutrition and anemia. The iron deficiency anemia therapy market faces constraints due to supplement side effects, such as digestive issues and allergies.

The oral iron therapy segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the type, the iron deficiency anemia therapy market size is divided into oral iron therapy, parenteral iron therapy, red blood cell transfusions, and others. Among these, the oral iron therapy segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. Oral iron therapy is favored for mild to moderate anemia due to its affordability, ease of use, and growing demand in emerging markets. It is less costly than IV iron and does not need specialized administration.

The adults segment accounted for the largest share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.

Based on the age group, the iron deficiency anemia therapy market size is divided into adults, pediatric, and geriatric. Among these, the adults segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Anemia is highly previzealent among women of childbearing age, pregnant women, and those with chronic conditions. According to the WHO, nearly one-third of non-pregnant and over 40% of pregnant women worldwide are affected due to increased iron needs, menstrual blood loss, and pregnancy-related deficiencies.

The hospitals segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end-user, the iron deficiency anemia therapy market size is divided into clinics, hospitals, and home healthcare. Among these, the hospitals segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Hospitals serve as primary centers for administering IV iron therapy, blood transfusions, and managing complex anemia linked to CKD, cancer, and IBD. Patients with moderate to severe anemia often require intensive care, making hospitalization the preferred treatment setting.

North America is expected to hold the majority share of the global iron deficiency anemia therapy market during the forecast period.

North America is expected to hold the majority share of the global iron deficiency anemia therapy market size during the forecast period. Market growth is further supported by the adoption of advanced oral and IV iron therapies. In the U.S., significant market share is driven by favorable reimbursement, robust hospital networks, government anemia screening programs, rising chronic disease prevalence, and increasing demand for effective anemia treatments.

Asia Pacific is anticipated to grow at the fastest pace in the global iron deficiency anemia therapy market size during the forecast period. The region’s growth is driven by a large population, high anemia prevalence, and improved healthcare access. India leads due to programs such as Anemia Mukt Bharat, while urbanization, enhanced hospitals, government initiatives, and rising awareness in China and Southeast Asia further boost the market.

Major vendors in the global iron deficiency anemia therapy market size are Akebia Therapeutics Inc., Bayer AG, AbbVie Inc., Pharmacosmos AS, Daiichi Sankyo, Johnson and Johnson, Pfizer Inc., AMAG Pharmaceuticals Inc., Apotex Inc., Sanofi SA, Rockwell Medical, Inc., Vifor Pharma Management Ltd., AdvaCare Pharma, Fresenius SE & Co. KGaA, and Others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Key Market Development 

• In May 2025, SteinCares and Pharmacosmos introduced Monofer, an IV iron therapy, across six Latin American countries. The collaboration emphasizes SteinCares’ dedication to providing affordable, high-quality treatments while connecting global specialty care innovations to the region’s unmet healthcare needs.

• In February 2021, Rockwell Medical announced that Triferic AVNU (ferric pyrophosphate citrate injection), the IV formulation of Triferic, is now available to patients in the U.S. The biopharmaceutical company aims to transform iron deficiency and anemia management, improving treatment outcomes for patients worldwide.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the iron deficiency anemia therapy market based on the below-mentioned segments:

Global Iron Deficiency Anemia Therapy Market, By Type

• Oral Iron Therapy
• Parenteral Iron Therapy
• Red Blood Cell Transfusions
• Others

Global Iron Deficiency Anemia Therapy Market, By Age Group

• Adults
• Pediatric
• Geriatric

Global Iron Deficiency Anemia Therapy Market, By End-user

• Clinics
• Hospitals
• Home Healthcare

 Global Iron Deficiency Anemia Therapy Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter